Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Dr. Salauddin Al Azad | Infectious Diseases Prevention | Best Researcher Award

Principal Investigator | Jiangnan University | China

Dr. Salauddin Al Azad is an accomplished researcher and CSC Scholar at the Key Laboratory of Industrial Biotechnology, Jiangnan University, China, and Principal Investigator of the RPG Interface Lab, Bangladesh. His research primarily focuses on synthetic biology, molecular engineering, and biorefinery processes for sustainable bioenergy production. He has made significant contributions to microbial lipid-based biorefineries, lignocellulosic biomass fractionation, molecular docking, and computational biochemistry. His expertise spans wet-lab techniques such as enzymatic hydrolysis, gene sequencing, and nanoencapsulation, as well as dry-lab and in silico methods including molecular dynamics simulation, density functional theory, and machine learning-driven bioprocess optimization. Salauddin’s multidisciplinary research integrates biochemistry, nanobiocomposite design, and immunoinformatics to develop advanced strategies for biofuel production, drug delivery, and enzyme stabilization. With 33 publications, including 20 indexed in SCI journals and 12 in Q1, his scientific contributions have gained substantial recognition, achieving 856 citations, an h-index of 19, and an i10-index of 25. His recent works in high-impact journals such as Biofuel Research Journal, Fuel, ACS Sustainable Chemistry & Engineering, and Bioresource Technology highlight innovations in green chemistry, computational modeling, and sustainable energy technologies. He has collaborated extensively with global research institutions and contributed as a reviewer and editorial board member for reputed publishers, reflecting his academic influence. Salauddin’s projects have been supported by the National Natural Science Foundation of China, the World Bank, and the Bangladesh Academy of Science, among others. His dedication to advancing molecular biotechnology, bioenergy, and material science has positioned him among the top global researchers in fields like biopolymer engineering, nanobiocomposites, and functional lipids. 492 Citations, 20 Documents, 13 h-index, View h-index.

Profiles : Scopus | ORCID

Featured Publications

Al Azad, S., Madadi, M., Saleknezhad, M., Zhang, E., & Sun, F. (2025). Machine learning-driven optimization of biphasic pretreatment conditions for enhanced lignocellulosic biomass fractionation. Energy, 136241. Cited by 8

Al Azad, S., Madadi, M., Rahman, A., Sun, C., Zhang, E., & Sun, F. (2025). Quantum mechanical insights into lignocellulosic biomass fractionation through an NaOH-catalyzed Triton-X 100 system: In vitro and in silico approaches. ACS Sustainable Chemistry & Engineering, 13(15), 5516–5530. Cited by 3

Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Prof. Amel Bouzabata | Treatment for Infectious Diseases | Best Paper Award

Professor | Badji-Mokhtar University | Algeria

Prof. Amel Bouzabata is a distinguished researcher and academic at Université Badji Mokhtar – Annaba, Algeria, recognized for her expertise in analytical chemistry, phytochemistry, and antioxidant studies. She obtained her Ph.D. in Analytical Chemistry from the same university in 2014, where she developed an early interest in the metabolic profiling of natural compounds and the bioactive evaluation of medicinal plants. Over the years, Prof. Bouzabata has built a strong academic and research portfolio focused on natural product analysis, chromatographic techniques, and high-resolution mass spectrometry (HR-LC-ESI-Orbitrap-MS). Her professional experience includes teaching undergraduate and postgraduate chemistry courses, supervising graduate theses, and participating in interdisciplinary research projects that link chemistry with pharmacology and environmental science. She has collaborated with international researchers to explore the biochemical diversity of regional flora, contributing to several peer-reviewed publications in Scopus-indexed and Q1 journals such as Antioxidants and Journal of Natural Products. Her research interests extend to metabolomics, chemometric analysis, and the discovery of novel antioxidant and antimicrobial compounds from natural sources. Prof. Bouzabata’s research skills include advanced chromatographic separation, spectral interpretation, multivariate data analysis, and the use of bioassay-guided fractionation for compound identification. She has received institutional recognition for her scientific contributions and is actively involved in promoting research capacity development among young scientists in Algeria. Through mentorship and collaboration, she has strengthened the university’s research visibility and global academic partnerships. Prof. Bouzabata continues to pursue innovative approaches to natural compound characterization, integrating analytical precision with biological relevance to address emerging scientific and health challenges. Her dedication to high-quality research and international collaboration underscores her growing influence in chemical and biological sciences. Prof. Amel Bouzabata has achieved 420 total citations across 15 published research documents, demonstrating a consistent scholarly impact with an h-index of 11, based on 376 citing documents in Scopus.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Bouzabata, A., Montoro, P., Gil, K. A., Piacente, S., et al. (2022). HR-LC-ESI-Orbitrap-MS-Based metabolic profiling coupled with chemometrics for the discrimination of different Echinops spinosus organs and evaluation of their antioxidant activity.

2. Bouzabata, A. (2015). Contribution à l’étude d’une plante médicinale et aromatique Myrtus communis L. Faculté de Médecine, Université Badji-Mokhtar, Annaba, Algérie.

3. Bouzabata, A., Bighelli, A., Abed, L., Casanova, J., & Tomi, F. (2014). Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Natural Product Communications, 9(5), 1934578X1400900530.

4. Bouzabata, A., & Yavuz, M. (2019). Médecine traditionnelle et ethnopharmacologie en Algérie: de l’histoire à la modernité. Ethnopharmacologia.

5. Bouzabata, A., & Boukhari, A. (2014). Variation in the traditional knowledge of Curcuma longa L. in North-Eastern Algeria. International Journal of Biological, Veterinary, Agricultural and Food Engineering.

 

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Mrs. Jing Wu | Infectious Diseases | Best Researcher Award

Nanjing First Hospital | China.

Author Profile

Scopus

🎓Education

Mrs. Jing Wu graduated from Nanjing Medical University, where she developed a strong foundation in imaging and diagnostic techniques.

💼Professional Experience

Currently, Mrs. Wu is a key member of the Department of Imaging at Nanjing Hospital, affiliated with Nanjing Medical University (Nanjing First Hospital). She specializes in respiratory imaging diagnosis and respiratory infection diagnosis, with extensive clinical and research experience.

🔬Technical Skills

Mrs. Wu is proficient in CT and MRI imaging, utilizing advanced techniques to diagnose and assess chest infections. She also has expertise in multidisciplinary team discussions and radiographic interpretation.

🔬Research Interests

Her research primarily focuses on chest infections, respiratory diseases, and advanced imaging techniques for diagnosis. She aims to improve diagnostic accuracy and treatment approaches for pulmonary conditions through innovative imaging.

📚Academic Contributions 

With over 20 published papers in prominent medical journals over the past five years, Mrs. Wu has significantly contributed to the field of respiratory imaging. Her notable works include articles on COVID-19 pneumonia, pulmonary infections, and Chlamydia psittaci pneumonia. Her impactful research can be found in journals like Eur Radiol, Quant Imaging Med Surg, and BMC Infect Dis.

🏅Achievements and Awards

Mrs. Wu has earned several prestigious awards, including the Second place in the China Radiographic Reading Competition and First prize in the Nanjing Medical University Young Doctor Lecture Competition. Her accolades showcase her leadership and expertise in radiology and chest imaging.

🎙️Teaching Experience

As a speaker at major conferences like the Chinese Radiology and Respiratory Annual Conference and the North American Radiology Conference, Mrs. Wu has shared her expertise in imaging diagnostics with peers and aspiring professionals.

📚Books & Reviews

Mrs. Wu has co-authored two professional books and served as the deputy editor-in-chief. She is also a dedicated peer reviewer for the Chinese Journal of Tuberculosis and Respiratory Medicine.

🌍Global Contributions

She continues to play a significant role in the international radiology community, sharing her research and findings to advance the field of respiratory imaging diagnostics.

Mrs. Wu’s exceptional skills and contributions make her a key figure in respiratory imaging diagnosis with a profound impact on clinical practice and medical education.

📑Notable Publications

“Chlamydia psittaci pneumonia – evolutionary aspects on chest CT”

Authors: Yang, N., Ou, Z., Sun, Q., Wu, J., Xue, C.
Publication Year: 2025
Journal: BMC Infectious Diseases

“Diagnosis and treatment experience of Chlamydia psittaci pneumonia: A multicenter retrospective study in China”

Authors: Deng, H., Shi, Y., Xie, M., Pan, L., Xue, X.
Publication Year: 2024
Journal: BMC Infectious Diseases

“Imaging analysis of pneumonic plague infection in Xizang, China: a case report and literature review”

Authors: Wang, W., Li, X., Wu, J., Fu, X., Li, B.
Publication Year: 2024
Journal: BMC Pulmonary Medicine

“CT and MRI Findings of Renal Angiomyolipoma With Lung Metastasis: A Case Report and Literature Review”

Authors: He, Z., Wu, J., Fu, X., Xu, H., Chen, Y.-C.
Publication Year: 2024
Journal: Clinical Respiratory Journal

“Clinical and CT diagnosis of 50 cases of Chlamydia psittaci pneumonia”

Authors: Wu, J., Pan, J., Han, C., Zhang, K., Chen, Y.-C.
Publication Year: 2023
Journal: Quantitative Imaging in Medicine and Surgery

Ms. Chen Xue | Chest infections | Best Researcher Award

Ms. Chen Xue | Chest infections | Best Researcher Award

Nanjing Medical University | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Ms. Chen Xue graduated from Nanjing Medical University with a master’s degree in Medical Imaging and Nuclear Medicine. During her academic journey, she developed a strong foundation in advanced radiological techniques and diagnostic methodologies, setting the stage for her specialized career in medical imaging.

💼PROFESSIONAL ENDEAVORS

Ms. Chen serves in the Department of Radiology at Nanjing Brain Hospital, where she specializes in the diagnosis of central nervous system (CNS) and chest infection lesions. Her work combines clinical precision and innovation, addressing complex cases with an interdisciplinary approach that ensures accurate and effective patient care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS OF INFECTIOUS DISEASES

Ms. Chen’s research focuses on improving the diagnostic accuracy of infectious diseases, particularly those affecting the CNS and respiratory system. By integrating advanced imaging technologies with novel diagnostic protocols, she is making significant strides in early detection and management of these conditions.

🌍IMPACT AND INFLUENCE

Through her work, Ms. Chen has enhanced global medical practices, particularly in the domain of infection-related imaging. Her contributions to radiological diagnostics are influencing healthcare policies and inspiring collaborations among specialists across disciplines.

📚ACADEMIC CITES

Ms. Chen has authored and co-authored numerous SCI-indexed papers, which are frequently cited in leading scientific journals. These works focus on innovative diagnostic techniques and their application in infectious diseases, highlighting her expertise and thought leadership.

🏆RESEARCH GRANTS AND FUNDING

Ms. Chen has secured significant research grants to support her pioneering work in radiological imaging and its application to infectious disease diagnostics. These funds enable her to explore new technologies and methodologies that improve diagnostic precision.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Ms. Chen is dedicated to shaping the future of medical imaging. She envisions the integration of artificial intelligence (AI) and machine learning into radiological practices to enhance the speed and accuracy of infectious disease diagnosis. Her commitment to mentoring young radiologists ensures her enduring impact on the field.

🌟A VISIONARY IN INFECTIOUS DISEASES

Ms. Chen Xue is a visionary leader in the field of infectious disease diagnostics, merging clinical expertise with innovative research. Her work is paving the way for more effective diagnostic tools and personalized treatment options, addressing global healthcare challenges.

📑NOTABLE PUBLICATIONS 

“Chlamydia psittaci pneumonia – evolutionary aspects on chest CT”

Authors: Yang, N., Ou, Z., Sun, Q., Wu, J., Xue, C.
Publication Year: 2025
Journal: BMC Infectious Diseases

“MRI-Negative Temporal Lobe Epilepsy: A Study of Brain Structure in Adults Using Surface-Based Morphological Features”

Authors: He, Y., Huang, Y., Guo, Z., Xiao, C., Chai, X.
Publication Year: 2024
Journal: Journal of Integrative Neuroscience

“Directed Functional Connectivity Changes of Triple Networks for Stable and Progressive Mild Cognitive Impairment”

Authors: Zheng, D., Ruan, Y., Cao, X., Huang, Q., Xue, C.
Publication Year: 2024
Journal: Neuroscience

“Shared and Specific Changes of Cortico-Striatal Functional Connectivity in Stable Mild Cognitive Impairment and Progressive Mild Cognitive Impairment”

Authors: Ruan, Y., Zheng, D., Guo, W., Xue, C., Xiao, C.
Publication Year: 2024
Journal: Journal of Alzheimer’s Disease

“Progressing researches on brain structural magnetic resonance in the conversion from stable to progressive mild cognitive impairment | 轻度认知障碍稳定型向进展型转化的脑结构磁共振成像研究进展”

Authors: Zheng, D., Xue, C., Huang, Q.
Publication Year: 2024
Journal: Chinese Journal of Behavioral Medicine and Brain Science

Introduction of Antibiotic

Introduction of Antibiotic

Antibiotics are powerful medications used to treat infections caused by bacteria. They work by killing bacteria or inhibiting their growth, helping to cure infections that would otherwise become severe or life-threatening. Antibiotics have revolutionized modern medicine since their discovery, drastically reducing mortality from bacterial infections. However, the misuse and overuse of antibiotics have led to increasing levels of antibiotic resistance, posing a significant threat to global health.

  • Types of Antibiotics:
  1. Broad-spectrum Antibiotics:
    These antibiotics work against a wide variety of bacteria, both Gram-positive and Gram-negative. Examples include:

    • Amoxicillin
    • Tetracycline
    • Ciprofloxacin
  2. Narrow-spectrum Antibiotics:
    These antibiotics target specific types of bacteria. Examples include:

    • Penicillin G (used mainly against Gram-positive bacteria)
    • Vancomycin (used against resistant Gram-positive bacteria)
  3. Bactericidal Antibiotics:
    These kill bacteria by attacking their cell walls or vital cellular functions. Examples include:

    • Penicillin
    • Cephalosporins
    • Aminoglycosides
  4. Bacteriostatic Antibiotics:
    These inhibit bacterial growth by interfering with bacterial protein production or DNA replication. Examples include:

    • Tetracycline
    • Sulfonamides
    • Chloramphenicol
  • How Antibiotics Work:
  • Antibiotics target key processes in bacteria that are essential for their survival and replication. These include:
  • Cell wall synthesis inhibition: Prevents bacteria from forming cell walls, leading to cell death (e.g., Penicillin).
  • Protein synthesis inhibition: Disrupts bacterial ribosomes, which produce proteins essential for cell function (e.g., Tetracycline).
  • DNA replication inhibition: Prevents bacterial DNA replication, halting cell division (e.g., Quinolones).
  • Cell membrane disruption: Damages bacterial cell membranes, leading to cell death (e.g., Polymyxins).

    Examples of Antibiotic-Resistant Bacteria:

    1. Methicillin-resistant Staphylococcus aureus (MRSA): Resistant to many antibiotics, causing serious skin infections.
    2. Vancomycin-resistant Enterococci (VRE): Often found in hospital-acquired infections.
    3. Carbapenem-resistant Enterobacteriaceae (CRE): Highly resistant to most antibiotics and often fatal.
    4. Multidrug-resistant Mycobacterium tuberculosis (MDR-TB): Resistant to the two most powerful anti-TB drugs, requiring complex and prolonged treatment.
  • Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

Introduction of Animal infectious diseases Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species.